Literature DB >> 33837517

Human Induced Pluripotent Stem Cell (iPSC) Handling Protocols: Maintenance, Expansion, and Cryopreservation.

Davide Marotta1, Chandrika Rao1, Valentina Fossati2.   

Abstract

Human induced pluripotent stem cells (iPSCs) have emerged as an invaluable resource for basic research, disease modeling, and drug discovery over recent years. Given the numerous advantages of iPSCs over alternative models-including their human origin, their ability to be differentiated into almost any cell type, and the therapeutic potential of patient-specific iPSCs in personalized medicine-many labs are now considering iPSC models for their studies. As the quality of the starting population of iPSCs is a key determinant in the success of any one of these applications, it is crucial to adhere to best practices in iPSC culture. In the following protocol, we offer a comprehensive guide to the culture, cryopreservation, and quality control methods required for the establishment and maintenance of high-quality iPSC cultures.
© 2021. Springer Science+Business Media, LLC.

Entities:  

Keywords:  Cell culture; Cryopreservation; Human induced pluripotent stem cells; Pluripotency

Mesh:

Year:  2022        PMID: 33837517     DOI: 10.1007/7651_2021_358

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  13 in total

1.  Automated, high-throughput derivation, characterization and differentiation of induced pluripotent stem cells.

Authors:  Daniel Paull; Ana Sevilla; Hongyan Zhou; Aana Kim Hahn; Hesed Kim; Christopher Napolitano; Alexander Tsankov; Linshan Shang; Katie Krumholz; Premlatha Jagadeesan; Chris M Woodard; Bruce Sun; Thierry Vilboux; Matthew Zimmer; Eliana Forero; Dorota N Moroziewicz; Hector Martinez; May Christine V Malicdan; Keren A Weiss; Lauren B Vensand; Carmen R Dusenberry; Hannah Polus; Karla Therese L Sy; David J Kahler; William A Gahl; Susan L Solomon; Stephen Chang; Alexander Meissner; Kevin Eggan; Scott A Noggle
Journal:  Nat Methods       Date:  2015-08-03       Impact factor: 28.547

Review 2.  Induced pluripotent stem cell technology: a decade of progress.

Authors:  Yanhong Shi; Haruhisa Inoue; Joseph C Wu; Shinya Yamanaka
Journal:  Nat Rev Drug Discov       Date:  2016-12-16       Impact factor: 84.694

3.  Recombinant human laminin isoforms can support the undifferentiated growth of human embryonic stem cells.

Authors:  Takamichi Miyazaki; Sugiko Futaki; Kouichi Hasegawa; Miwa Kawasaki; Noriko Sanzen; Maria Hayashi; Eihachiro Kawase; Kiyotoshi Sekiguchi; Norio Nakatsuji; Hirofumi Suemori
Journal:  Biochem Biophys Res Commun       Date:  2008-08-12       Impact factor: 3.575

4.  Laminin isoforms in human embryonic stem cells: synthesis, receptor usage and growth support.

Authors:  Sanna Vuoristo; Ismo Virtanen; Minna Takkunen; Jaan Palgi; Yamato Kikkawa; Patricia Rousselle; Kiyotoshi Sekiguchi; Timo Tuuri; Timo Otonkoski
Journal:  J Cell Mol Med       Date:  2008-12-29       Impact factor: 5.310

5.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

6.  Recombinant vitronectin is a functionally defined substrate that supports human embryonic stem cell self-renewal via alphavbeta5 integrin.

Authors:  Stefan R Braam; Laura Zeinstra; Sandy Litjens; Dorien Ward-van Oostwaard; Stieneke van den Brink; Linda van Laake; Franck Lebrin; Peter Kats; Ron Hochstenbach; Robert Passier; Arnoud Sonnenberg; Christine L Mummery
Journal:  Stem Cells       Date:  2008-07-03       Impact factor: 6.277

7.  A ROCK inhibitor permits survival of dissociated human embryonic stem cells.

Authors:  Kiichi Watanabe; Morio Ueno; Daisuke Kamiya; Ayaka Nishiyama; Michiru Matsumura; Takafumi Wataya; Jun B Takahashi; Satomi Nishikawa; Shin-ichi Nishikawa; Keiko Muguruma; Yoshiki Sasai
Journal:  Nat Biotechnol       Date:  2007-05-27       Impact factor: 54.908

8.  Feeder layer- and serum-free culture of human embryonic stem cells.

Authors:  M Amit; C Shariki; V Margulets; J Itskovitz-Eldor
Journal:  Biol Reprod       Date:  2003-11-19       Impact factor: 4.285

9.  Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

Authors:  Luigi Warren; Philip D Manos; Tim Ahfeldt; Yuin-Han Loh; Hu Li; Frank Lau; Wataru Ebina; Pankaj K Mandal; Zachary D Smith; Alexander Meissner; George Q Daley; Andrew S Brack; James J Collins; Chad Cowan; Thorsten M Schlaeger; Derrick J Rossi
Journal:  Cell Stem Cell       Date:  2010-09-30       Impact factor: 24.633

10.  Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome.

Authors:  Noemi Fusaki; Hiroshi Ban; Akiyo Nishiyama; Koichi Saeki; Mamoru Hasegawa
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2009       Impact factor: 3.493

View more
  1 in total

1.  Proteomic Alterations and Novel Markers of Neurotoxic Reactive Astrocytes in Human Induced Pluripotent Stem Cell Models.

Authors:  David Labib; Zhen Wang; Priya Prakash; Matthew Zimmer; Matthew D Smith; Paul W Frazel; Lilianne Barbar; Maria L Sapar; Peter A Calabresi; Junmin Peng; Shane A Liddelow; Valentina Fossati
Journal:  Front Mol Neurosci       Date:  2022-05-03       Impact factor: 6.261

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.